Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Satter Muneer A
Relationship:   Director, 10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   0    

Indirect Shares

   60,789,542      
Direct Value   $0    

Indirect Value

   $81,924,391      
Total Shares   60,789,542      
Total Value   $81,924,391      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   8.9%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            DFC Global Corp DLLR Director 0 2005-01-27 1,193,504    Premium*  
            HeartWare International Inc HTWR 10% Owner 2008-04-14 0 2008-07-11 25,150,000    Premium*  
            Akebia Therapeutics, Inc. AKBA Director 2014-03-25 0 2017-07-05 3,037,042    Premium*  
            Immunic Inc IMUX Director, 10% Owner 0 2018-09-17 0    Premium*  
            Eledon Pharmaceuticals Ord Shs ELDN 10% Owner 2014-09-22 0 2014-09-22 1,771,688    Premium*  
            Aadi Bioscience, Inc AADI Director, 10% Owner 2017-03-15 0 2019-01-10 5,621,835    Premium*  
            Aileron Therapeutics Inc ALRN See Remarks, Director 2017-07-05 0 2021-01-08 16,609,449    Premium*  
            Annexon, Inc. ANNX Director, 10% Owner 2020-07-28 0 2023-12-26 7,406,024    Premium*  
* Premium Members only  

Records found :    91         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AADI Aadi Bioscience, Inc Director   –       •       •   2018-12-28 4 B $1.72 $34,372 I/I 20,000 5,458,017 2.25 -
AADI Aadi Bioscience, Inc Director   –       •       •   2018-12-31 4 B $1.75 $34,900 I/I 20,000 5,478,017 2.25 -
AADI Aadi Bioscience, Inc Director   –       •       •   2019-01-02 4 B $1.94 $38,838 I/I 20,000 5,498,017 2.25 -
AADI Aadi Bioscience, Inc Director   –       •       •   2019-01-03 4 B $2.08 $41,508 I/I 20,000 5,518,017 2.25 -
AADI Aadi Bioscience, Inc Director   –       •       •   2019-01-04 4 B $2.12 $42,396 I/I 20,000 5,538,017 2.25 -
AADI Aadi Bioscience, Inc Director   –       •       •   2019-01-07 4 B $2.18 $43,558 I/I 20,000 5,558,017 2.25 -
AADI Aadi Bioscience, Inc Director   –       •       •   2019-01-08 4 B $2.20 $43,972 I/I 20,000 5,578,017 2.25 -
AADI Aadi Bioscience, Inc Director   –       •       •   2019-01-09 4 B $2.39 $47,876 I/I 20,000 5,598,017 2.25 -
AADI Aadi Bioscience, Inc Director   –       •       •   2019-01-10 4 B $2.45 $58,442 I/I 23,818 5,621,835 2.25 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-03-25 4 A $0.00 $0 I/I 1,441,265 1,441,265 0 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-03-25 4 B $17.00 $1,552,015 I/I 91,295 1,532,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-11-12 4 B $10.85 $59,515 I/I 5,000 1,537,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-11-13 4 B $11.56 $57,800 I/I 5,000 1,542,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-11-14 4 B $11.91 $59,550 I/I 5,000 1,547,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-11-17 4 B $12.94 $64,700 I/I 5,000 1,552,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-11-18 4 B $13.84 $69,200 I/I 5,000 1,557,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-11-19 4 B $14.85 $74,250 I/I 5,000 1,562,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-11-20 4 B $14.70 $73,500 I/I 5,000 1,567,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-11-21 4 B $14.73 $73,650 I/I 5,000 1,572,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-11-24 4 B $13.88 $69,400 I/I 5,000 1,577,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2014-11-25 4 B $13.18 $65,900 I/I 5,000 1,582,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2015-04-22 4 B $8.25 $3,465,000 I/I 420,000 2,002,560 2.1 -
AKBA Akebia Therapeutics, Inc. Director   –       •      –    2017-07-05 4 B $14.50 $14,999,989 I/I 1,034,482 3,037,042 2.1 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2017-07-05 4 A $0.00 $0 I/I 144,773 144,773 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2017-07-05 4 B $15.00 $499,995 I/I 33,333 178,106 1.5 -
  91  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us